⌘K

Login Start Free

Home/Filings/4/0001209191-21-007809

4//SEC Filing

Graves Michael 4

Accession 0001209191-21-007809

CIK 0000827871other

View on SEC.gov Company Profile

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 5:13 PM ET

Size

5.4 KB

Accession

0001209191-21-007809

Insider Transaction Report

Form 4

Period: 2021-02-02

EAGLE PHARMACEUTICALS, INC.EGRX

Director

Transactions

Award
Stock Option (right to buy)
2021-02-02+13,500→ 13,500 total
Exercise: $49.32Exp: 2031-02-02→ Common Stock (13,500 underlying)

Footnotes (1)

[F1]The option fully vests on February 2, 2022, subject to the Reporting Person's continuous service with the Issuer as of the vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

EAGLE PHARMACEUTICALS, INC.

CIK 0000827871

Entity typeother

Related Parties

1

filerCIK 0001339978

Filing Metadata

Form type: 4
Filed: Feb 3, 7:00 PM ET
Accepted: Feb 4, 5:13 PM ET
Size: 5.4 KB

View on SEC.gov